Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Acta Biomater. 2014 Mar 13;10(7):2935–2944. doi: 10.1016/j.actbio.2014.03.005

Figure 3.

Figure 3

Quantification of plasmid-containing bacteria (a) and number of viable cells (b). (a) S. aureus cells containing pAmiBLAZ or pAmiSPA previous to implantation and 7 days-post implantation was screened on TSA plates supplemented with chloramphenicol (10 μg mL−1). (b) The number of viable S. aureus Xen29 cells previous to implantation and 7 days-post implantation determined on TSA kanamycin (50 μg mL−1) plates.